Clinical Trial Update: Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy followed by donor stem cell transplant in relapsed or high-risk primary refractory Hodgkin lymphoma completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28